Nanosonics Limited
Nanosonics Limited operates as an infection prevention company in Australia, North America, Europe, the United Kingdom, the Middle East, and Asia Pacific. The company manufactures and distributes trophon ultrasound probe disinfector, and its related consumables and accessories; and research, develops, and commercialize of infection control and decontamination products and related technologies. It… Read more
Nanosonics Limited (NNCSF) - Net Assets
Latest net assets as of June 2025: $209.91 Million USD
Based on the latest financial reports, Nanosonics Limited (NNCSF) has net assets worth $209.91 Million USD as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($272.48 Million) and total liabilities ($62.57 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $209.91 Million |
| % of Total Assets | 77.04% |
| Annual Growth Rate | 20.81% |
| 5-Year Change | 54.84% |
| 10-Year Change | 270.45% |
| Growth Volatility | 31.82 |
Nanosonics Limited - Net Assets Trend (2013–2025)
This chart illustrates how Nanosonics Limited's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Nanosonics Limited (2013–2025)
The table below shows the annual net assets of Nanosonics Limited from 2013 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-06-30 | $209.91 Million | +15.21% |
| 2024-06-30 | $182.20 Million | +11.19% |
| 2023-06-30 | $163.86 Million | +18.15% |
| 2022-06-30 | $138.69 Million | +2.30% |
| 2021-06-30 | $135.57 Million | +9.13% |
| 2020-06-30 | $124.23 Million | +12.85% |
| 2019-06-30 | $110.08 Million | +16.73% |
| 2018-06-30 | $94.30 Million | +8.08% |
| 2017-06-30 | $87.25 Million | +53.98% |
| 2016-06-30 | $56.66 Million | +26.83% |
| 2015-06-30 | $44.68 Million | +118.62% |
| 2014-06-30 | $20.43 Million | -5.86% |
| 2013-06-30 | $21.71 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Nanosonics Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 11382700000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (June 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $58.39 Million | 27.82% |
| Common Stock | $114.86 Million | 54.72% |
| Other Comprehensive Income | $36.66 Million | 17.47% |
| Total Equity | $209.91 Million | 100.00% |
Nanosonics Limited Competitors by Market Cap
The table below lists competitors of Nanosonics Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
GRAY TELEVISION A DL-01
F:GCZA
|
$714.50 Million |
|
Ta Ya Electric Wire & Cable Co., Ltd.
TW:1609
|
$714.51 Million |
|
BYTES TECH.GRP LS -01
F:9NY
|
$714.57 Million |
|
BioGaia AB (publ)
ST:BIOG-B
|
$714.80 Million |
|
Zhenjiang Dongfang Electric Heat
SHE:300217
|
$713.56 Million |
|
Greencore Group plc
PINK:GNCGF
|
$713.42 Million |
|
Nippon Paper Industries Co. Ltd
F:9NI
|
$713.41 Million |
|
Uxin Ltd
NASDAQ:UXIN
|
$713.35 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Nanosonics Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 182,202,000 to 209,910,000, a change of 27,708,000 (15.2%).
- Net income of 20,676,000 contributed positively to equity growth.
- New share issuances of 310,000 increased equity.
- Other comprehensive income increased equity by 6,722,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $20.68 Million | +9.85% |
| Share Issuances | $310.00K | +0.15% |
| Other Comprehensive Income | $6.72 Million | +3.2% |
| Total Change | $- | 15.21% |
Book Value vs Market Value Analysis
This analysis compares Nanosonics Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 4.09x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 33.45x to 4.09x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2013-06-30 | $0.08 | $2.78 | x |
| 2014-06-30 | $0.08 | $2.78 | x |
| 2015-06-30 | $0.17 | $2.78 | x |
| 2016-06-30 | $0.20 | $2.78 | x |
| 2017-06-30 | $0.29 | $2.78 | x |
| 2018-06-30 | $0.31 | $2.78 | x |
| 2019-06-30 | $0.36 | $2.78 | x |
| 2020-06-30 | $0.41 | $2.78 | x |
| 2021-06-30 | $0.44 | $2.78 | x |
| 2022-06-30 | $0.45 | $2.78 | x |
| 2023-06-30 | $0.53 | $2.78 | x |
| 2024-06-30 | $0.59 | $2.78 | x |
| 2025-06-30 | $0.68 | $2.78 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Nanosonics Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 9.85%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 10.39%
- • Asset Turnover: 0.73x
- • Equity Multiplier: 1.30x
- Recent ROE (9.85%) is above the historical average (3.34%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2013 | -26.57% | -38.71% | 0.44x | 1.55x | $-7.94 Million |
| 2014 | -12.75% | -12.12% | 0.64x | 1.64x | $-4.65 Million |
| 2015 | -12.22% | -24.58% | 0.37x | 1.35x | $-9.93 Million |
| 2016 | 0.22% | 0.29% | 0.63x | 1.20x | $-5.54 Million |
| 2017 | 29.98% | 38.75% | 0.68x | 1.14x | $17.43 Million |
| 2018 | 6.10% | 9.48% | 0.55x | 1.17x | $-3.68 Million |
| 2019 | 12.36% | 16.18% | 0.64x | 1.18x | $2.59 Million |
| 2020 | 8.16% | 10.20% | 0.67x | 1.19x | $-2.29 Million |
| 2021 | 6.33% | 8.42% | 0.62x | 1.21x | $-4.98 Million |
| 2022 | 2.70% | 3.13% | 0.62x | 1.39x | $-10.13 Million |
| 2023 | 12.13% | 11.87% | 0.74x | 1.38x | $3.50 Million |
| 2024 | 7.12% | 7.63% | 0.72x | 1.30x | $-5.25 Million |
| 2025 | 9.85% | 10.39% | 0.73x | 1.30x | $-315.00K |
Industry Comparison
This section compares Nanosonics Limited's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $2,683,526,542
- Average return on equity (ROE) among peers: -32.48%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Nanosonics Limited (NNCSF) | $209.91 Million | -26.57% | 0.30x | $714.50 Million |
| ANGELALIGN TECHNOLOGY INC (AGLFF) | $480.24 Million | 2.52% | 0.41x | $405.57 Million |
| Akoya Biosciences Inc (AKYA) | $-30.16 Million | 0.00% | 0.00x | $16.24 Million |
| Alcon AG (ALC) | $19.68 Billion | 1.70% | 0.48x | $37.82 Billion |
| Align Technology Inc (ALGN) | $3.85 Billion | 10.94% | 0.61x | $11.75 Billion |
| AngioDynamics Inc (ANGO) | $355.71 Million | 3.06% | 0.15x | $354.40 Million |
| Ansell Limited (ANSLF) | $386.33 Million | -0.45% | 0.87x | $2.58 Billion |
| AptarGroup Inc (ATR) | $2.07 Billion | 11.57% | 1.03x | $8.27 Billion |
| AtriCure Inc (ATRC) | $72.60 Million | -15.79% | 0.54x | $1.42 Billion |
| Avinger Inc (AVGR) | $-35.69 Million | 0.00% | 0.00x | $1.26 Million |
| Anteris Technologies Global Corp. Common Stock (AVR) | $9.03 Million | -338.35% | 0.77x | $156.14 Million |